Pattern PS00108
PROTEIN_KINASE_ST
[LIVMFYC]-x-[HY]-x-D-[LIVMFY]-K-x(2)-N-[LIVMFYCT](3)
The following PDB entries contain known "true positive" matches for this PROSITE pattern, or matches that are highly likely to be correct.
1 | 26 | 51 | 76 | 101 | 126 | 151 | 176 |

.PDB..Code
Title
1a06  Calmodulin- dependent protein kinase from rat
1bi8  Mechanism of g1 cyclin dependent kinase inhibition from the structures cdk6- p19ink4d inhibitor complex
1blx  P19ink4d/cdk6 complex
1ckp  Human cyclin dependent kinase 2 complexed with the inhibitor purvalanol b
1ql6  The catalytic mechanism of phosphorylase kinase probed by mutational studies
1v0p  Structure of p. Falciparum pfpk5- purvalanol b ligand complex
1xo2  Crystal structure of a human cyclin- dependent kinase 6 compl flavonol inhibitor, fisetin
2ac3  Structure of human mnk2 kinase domain
2ac5  Structure of human mnk2 kinase domain mutant d228g
2eu9  Crystal structure of clk3
2exe  Crystal structure of the phosphorylated clk3
2h6d  Protein kinase domain of the human 5'- amp- activated protein kinase catalytic subunit alpha- 2 (ampk alpha- 2 chain)
2iwi  Crystal structure of the human pim2 in complex with a ruthenium organometallic ligand ru1
2j2i  Crystal structure of the humab pim1 in complex with ly333531
2jld  Extremely tight binding of ruthenium complex to glycogen synthase kinase 3
2lav  Nmr solution structure of human vaccinia- related kinase 1
2phk  The crystal structure of a phosphorylase kinase peptide subs complex: kinase substrate recognition
2vag  Crystal structure of di- phosphorylated human clk1 in complex with a novel substituted indole inhibitor
2vta  Identification of n- (4- piperidinyl)- 4- (2,6- dichlorobenzoylamino)- 1h- pyrazole- 3- carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment- based x- ray crystallography and structure based drug design.
2vth  Identification of n- (4- piperidinyl)- 4- (2,6- dichlorobenzoylamino)- 1h- pyrazole- 3- carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment- based x- ray crystallography and structure based drug design
2vti  Identification of n- (4- piperidinyl)- 4- (2,6- dichlorobenzoylamino)- 1h- pyrazole- 3- carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment- based x- ray crystallography and structure based drug design
2vtj  Identification of n- (4- piperidinyl)- 4- (2,6- dichlorobenzoylamino)- 1h- pyrazole- 3- carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment- based x- ray crystallography and structure based drug design
2vtl  Identification of n- (4- piperidinyl)- 4- (2,6- dichlorobenzoylamino)- 1h- pyrazole- 3- carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment- based x- ray crystallography and structure based drug design
2vtm  Identification of n- (4- piperidinyl)- 4- (2,6- dichlorobenzoylamino)- 1h- pyrazole- 3- carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment- based x- ray crystallography and structure based drug design
2vtn  Identification of n- (4- piperidinyl)- 4- (2,6- dichlorobenzoylamino)- 1h- pyrazole- 3- carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment- based x- ray crystallography and structure based drug design